Navigation Links
Receptors involved in corneal clarity identified

The researchers at the Aberdeen University have found out molecules that could aid in the treatment of cancer, heart diseases and other serious disorders//.

The expression of this molecule, sflt-1, a free-floating receptor for vascular endothelial growth factor A, prevents the formation of vision obstructing blood vessels, thus keeps the cornea clear.

According to the researchers, this discovery could help in the development of new drugs, new therapies for eye diseases and eye injuries. The Aberdeen team and colleagues at the Medical College of Georgia and the University of Kentucky in the US conducted this research.

Dr Martin Collinson, senior lecturer at the University of Aberdeen, said, "The molecule is an amazing finding". He added: "The cornea is widely used by scientists who hope to study how blood vessels grow or how to inhibit the growth of new blood vessels. "This knowledge will help to treat diseases like cancer, heart disease, rheumatoid arthritis, stroke and eye disorders like macular degeneration. "The cornea is our window on the world. If it contained blood vessels it would not be transparent and we would not be able to see. "If you study a normal eye you will see blood vessels in the whites of the eye but these stop at the cornea."

The cornea could get vascularised or form blood vessels due to disease or injury. Tumors are able to grow due to their capacity to attract blood vessels. Hence, vascularisation is crucial in diseases like cancer.
GYT
'"/>




Page: 1

Related medicine news :

1. Effects Of Certain Food Related To Single Pain Receptors
2. Inhibitor That Blocks Host Receptors Found To be Effective In Treating Anthrax
3. Max Planck Researchers Incorporate Odorant Receptors into Artificial Membranes
4. Nitric oxide involved in high blood pressure
5. Scientists locate key hormone involved in appetite control
6. Risks involved in Procedural Sedation
7. Toxin causing Gastrointestinal problems identified
8. Gene Variant associated with Schizophrenia identified
Post Your Comments:
(Date:10/7/2008)...t in post-HAART era , , TUESDAY, Oct. 7 ...earch finds little evidence that circumcision prot...ut the issue is still far from settled. , For o...werful AIDS drugs showed that circumcision did hav...nched the most definitive type of research into th...
(Date:10/7/2008)...ter at the University of California, San Diego (UC...less march of advanced lung cancer by treating pat...any vaccines attempt to pump up the immune system ...s genetically engineered to also trick the cancer ...ivities. , The first patients have begun enrolli...
(Date:10/7/2008)...quest comes at stem cell symposium, ANN ARBOR, Mi...ne year,ago, retail pioneer A. Alfred Taubman anno...igan, to endow a new research institute aimed at,u...e., Today, at the institute,s first symposium, he...an additional $22 million to the,University for th...
(Date:10/7/2008)...E NATION HAVE SAID ,I VOTE FOR THE ...ire/ -- To aid and help educate tonight,s debate,w...idential candidates,Senators John McCain and Barac...Susan G. Komen for the Cure(R) Advocacy Alliance t...ts web site --, http://www.IVotefortheCure.org ., ...
Breaking Medicine News(10 mins):Health News:Role of Circumcision in Reducing HIV Risk Still Unclear 2Health News:Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center 2Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3
...vidence to implicate insulin-like growth factor re...ase.// In a previous research, Terry J. Smith, M.... the interaction between immunoglobulins and IGF-1...ocyte infiltration in both Graves’ disease and rhe...
...ind a cure for deafness. As a leader in stem cell-...iversity School of Medicine,// he's got a step-by-... take another decade or so, but if anyone can do i...ur bets on. 'Everyone asks, 'How long before we d...
...tion of East Caribbean States (OECS) have said sch...ntion studies to their respective curricula. Arse... pandemic has raised concern of great magnitude in...tistics, the year 2006 saw 170,000 new cases of in...
...ally Administered Tribal Area (FARA) was the secon...t the immunization //drive carried out by the gove... chief surgeon at the main government hospital in ...olled roadside bomb exploded in Salarzai, a villag...
Other Medicine News:Health News:A Single Biological Mechanism Behind Several Autoimmune Disorders 2Health News:Stem Cell Transplants Explored as a Possible Treatment for Hearing Loss 2
(Date:10/7/2008)...tCall/ -- CEL-SCI Corporation,(NYSE: CVM ) announ...sfer,Agreement (MTA) with the National Institutes ...ry of Dr. Francesco M. Marincola, M.D., to,investi...icroenvironment,caused by CEL-SCI,s cancer drug Mu...ous Disease and Immunogentics Section, Department ...
(Date:10/7/2008).../ -- Aerovance Inc. today reported,pharmacokinetic...Aerovant,inhalation powder that demonstrate good t...llowing asthma patients, inhalation of a single 10... three doses investigated in,Aerovance,s Phase IIb...arly,next year. Evidence gathered from nonclinical...
(Date:10/7/2008)... Tests for Use on the GeneXpert(R) ...7 /- Cepheid (Nasdaq:,CPHD)...B as a European CE,IVD Mark product under the Euro...ces. The test delivers rapid detection of vanA and... with vancomycin-resistant,enterococci (VRE) -- on...
(Date:10/6/2008)...e/ -- "A return to the use of,chimpanzees in AIDS ...ific,justification," according to a paper released...nimals (ATLA). "An Assessment of the Role of,Chimp...ccine responses in,chimpanzees are not predictive ...zees, critical role and importance in AIDS vaccine...
Breaking Medicine Technology:CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Salugen to Present at Nutrition Capital Networks First In Person Investor Meeting 1154 1Salugen to Present at Nutrition Capital Networks First In Person Investor Meeting 1154 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 1University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 3Prostate cancer more likely to return in blacks than whites but the disease is not more aggressive 3212 1Prostate cancer more likely to return in blacks than whites but the disease is not more aggressive 3212 2Fruit and vegetables health 3210 1
...fety of Gene Therapy in Lipoprotein Lipase,Deficie... 31, 2007 - Amsterdam Molecular,Therapeutics (AMT)...orted positive Phase I/II clinical trial results w...MT-011) in Complete,Lipoprotein Lipase (LPL) defic...erican Society of Gene Therapy (ASGT) in Seattle.,...
...rom XL880, Phase II data from XL999 studies,schedu...-, SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswire-F...ata from clinical trials of,the company,s investig...d at the 2007 American Society of Clinical Oncolog...1 to 5 in Chicago,Illinois. , , -- Data from t...
Other Medicine Technology:AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 2AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 3AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 4Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: